What to know about COVID-19 study that was finally published after being blocked by CDC - ABC News - Breaking News, Late

Topic: healthRegion: globalUpdated: i1 outletsSources: 4Spectrum: Center Only⏱ 3 min read📡 Wire pickup

📰 Scored from 1 outletsacross 1 Center How we score bias →

Story Summary

SITUATION

The CDC has published a previously blocked COVID-19 vaccine efficacy study in JAMA after significant delays. This publication follows ongoing scrutiny regarding the transparency of vaccine data and its implications for public health policy.

Coveragetap to expand ▾

Spectrum: Center Only🌍Other: 2 · US: 1 · Africa: 1

Political Spectrum

Position is inferred from coverage mix.

i1 outlets · Center

Left

Center

Right

Left: 0

Center: 4

Right: 0

Geography Coverage

Distribution of where coverage is coming from.

i1 unique outlets · Dominant: Global

All4 US/CA1 · 25%Africa1 · 25%Global2 · 50%

KEY FACTS

COVID-19 vaccine study that was blocked from CDC journal is published elsewhere - AP News

HISTORICAL CONTEXT

The ongoing global health crisis stemming from the COVID-19 pandemic, which began in late 2019, has seen various developments in vaccine research and public health policy. As of 2026, the pandemic continues to influence health systems worldwide, with the emergence of new variants and the ongoing debate over vaccine efficacy.

In the United States, the Centers for Disease Control and Prevention (CDC) has faced scrutiny regarding its transparency and communication of data related to COVID-19 vaccines. This scrutiny intensified following the emergence of new variants in late 2021 and early 2022, which raised questions about the effectiveness of existing vaccines.

Brief

The Centers for Disease Control and Prevention (CDC) has finally published a COVID-19 vaccine efficacy study in the Journal of the American Medical Association (JAMA) after it was blocked for an extended period.

This report, which details the effectiveness of vaccines against various COVID-19 variants, has sparked renewed discussions about the transparency of health data and the implications for public health policy.

Critics of the CDC have voiced concerns regarding the agency's handling of vaccine data, arguing that the delays in publication have undermined public trust in health authorities. The publication follows mounting pressure from public health advocates and political figures who have called for greater transparency regarding vaccine efficacy.

The study's findings are expected to inform ongoing debates about vaccination strategies and public health responses to the pandemic. As the situation evolves, the implications of this publication for public health policy and vaccine uptake will be closely monitored.

Sources

4 of 4 linked articles